Old Web
English
Sign In
Acemap
>
authorDetail
>
Fernando Dela Cruz
Fernando Dela Cruz
Bayer Corporation
Receptor
Vasoactive intestinal peptide
Biology
Biochemistry
Agonist
3
Papers
186
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy
2007
Journal of Medicinal Chemistry
Joachim Rudolph
Libing Chen
Dyuti Majumdar
William H. Bullock
Michael C. Burns
Thomas H. Claus
Fernando Dela Cruz
Michelle Daly
Frederick J. Ehrgott
Jeffrey S. Johnson
James N. Livingston
Robert Schoenleber
Jeffrey Shapiro
Ling Yang
and Manami Tsutsumi
Xin Ma
Show All
Source
Cite
Save
Citations (47)
Generation of Highly Selective VPAC2 Receptor Agonists by High Throughput Mutagenesis of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Peptide
2003
Journal of Biological Chemistry
Stephanie L. Yung
Fernando Dela Cruz
Sarah Hamren
Jian Zhu
Manami Tsutsumi
James W. Bloom
Margaret Caudle
Steve Roczniak
Tracey Todd
Lynn Lemoine
Margit MacDougall
Armen B. Shanafelt
Clark Pan
Show All
Source
Cite
Save
Citations (36)
A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal: A Potential Therapy for Type 2 Diabetes
2002
Diabetes
Manami Tsutsumi
Thomas H. Claus
Yin Liang
Yaxin Li
Ling Yang
Jian Zhu
Fernando Dela Cruz
Xianbu Peng
Hongxing Chen
Stephanie L. Yung
Sarah Hamren
James N. Livingston
Clark Pan
Show All
Source
Cite
Save
Citations (103)
1